+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Controlled Release Drug Delivery Market by Route, Polymer, Type, Application, Technology, Drug Type, End User - Global Forecast to 2030- Product Image
Controlled Release Drug Delivery Market by Route, Polymer, Type, Application, Technology, Drug Type, End User - Global Forecast to 2030- Product Image
Sale

Controlled Release Drug Delivery Market by Route, Polymer, Type, Application, Technology, Drug Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337450
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The controlled release drug delivery market is undergoing transformative change, driven by advances in polymer science, nanotechnology, and integration with digital health platforms. Strategic partnerships, regulatory shifts, and evolving patient care models are shaping an industry that offers increasingly targeted and efficient therapies for a wide spectrum of conditions.

Market Snapshot: Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market grew from USD 46.70 billion in 2024 to USD 51.08 billion in 2025. It is expected to continue growing at a CAGR of 9.31%, reaching USD 79.70 billion by 2030. Increased adoption of intelligent dosing systems, focus on patient-centric care, and expansion into personalized medicine are accelerating new technology deployment. Industry stakeholders are responding to evolving performance, safety, and reimbursement criteria across regions, creating new routes to growth as systemic side effects become a core focus for value-based models. The convergence of innovative research, regulatory flexibility, and dynamic partnership models is broadening global reach, with companies leveraging both mature and emerging markets to sustain momentum.

Scope & Segmentation

This market research delivers a holistic perspective, structured around critical segments and key geographies to support informed executive decision-making.

  • Route: Implantable, Injectable, Nasal, Ocular, Oral, Pulmonary, Topical
  • Polymer:
    • Biodegradable: PCL, PLA, PLGA
    • Non-Biodegradable: Ethylene-Vinyl Acetate, Polyacrylate, Silicon
  • Type: Chemically-Controlled (Iontophoresis, pH Sensitive, Protonation), Diffusion-Controlled, Dissolution-Controlled, Osmotic, Stimuli-Induced (Magnetic, Temperature, Ultrasound)
  • Application: Cardiovascular, CNS Disorders, Infectious Diseases, Oncology, Pain Management
  • Technology: Liposomes (Conventional, Ligand-Targeted, PEGylated), Microencapsulation (Coacervation, Solvent Evaporation, Spray Drying), Microspheres (Chitosan, Gelatin, PLGA), Nanoparticles (Dendrimer, Inorganic, Lipid-Based, Polymeric)
  • Drug Type: Biologics (Monoclonal Antibodies, Peptides, Proteins, Vaccines), Small Molecule
  • End User: Clinics, Home Healthcare, Hospitals, Specialty Centers
  • Geography: Americas (including key states in the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with major markets such as the United Kingdom, Germany, France, United Arab Emirates, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, and Southeast Asia’s significant economies)
  • Leading Companies: Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Merck & Co., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc

Key Takeaways for Senior Executives

  • The market’s momentum is sustained by advancements in stimuli-responsive materials, enabling on-demand release profiling and enhancing personalized medicine strategies.
  • Manufacturers face complex procurement decisions and increased production costs due to ongoing tariff exposures and regional supply chain disruptions, prompting shifts toward local sourcing and new material evaluations.
  • Outcome-based reimbursement frameworks are rising in influence, pushing developers to focus on adherence rates, patient quality of life, and economic value beyond pharmacokinetics.
  • Collaborative ecosystems, comprising pharmaceutical firms, device specialists, digital health startups, and academic partners, are now pivotal in accelerating innovation and shortening time-to-market.
  • Segment diversity, from drug type to technology modality, enables a wide array of tailored solutions for chronic, acute, and specialty conditions—no single segment dominates all therapeutic needs or regions.

Tariff Impact

Recent US tariffs on raw materials, core polymers, and device inputs are introducing supply chain volatility and inflationary pressures. Larger multinationals are better able to absorb these risks, while emerging companies increasingly rely on contract manufacturing partners or strategic alliances. This industry divergence is leading to either investment in North American capacity or heightened partnerships across the value chain to sustain competitiveness. Downstream payers are intensifying value scrutiny, increasing the operational need for demonstrating economic and clinical outcomes.

Methodology & Data Sources

Insights are generated using rigorous primary interviews with R&D, regulatory, and commercial leaders, complemented by secondary sources such as peer-reviewed literature, regulatory publications, and validated market activity databases. Findings are supported by systematic segment analysis and scenario modeling, ensuring robust, actionable intelligence for executive planning.

Why This Report Matters

  • Provides a comprehensive blueprint for strategic planning, including insight into technology adoption and emerging partnership models.
  • Supports executives and R&D leaders in risk assessment and opportunity identification across geographies and therapeutic areas.
  • Empowers commercial teams to navigate evolving payer demands, supply chain risks, and regulatory requirements in an increasingly competitive environment.

Conclusion

The controlled release drug delivery market is defined by innovation, partnership, and adaptability to changing external pressures. Informed action based on this report’s insights can help stakeholders sustain growth and drive value in a rapidly evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Controlled Release Drug Delivery Market, by Route
8.1. Introduction
8.2. Implantable
8.3. Injectable
8.4. Nasal
8.5. Ocular
8.6. Oral
8.7. Pulmonary
8.8. Topical
9. Controlled Release Drug Delivery Market, by Polymer
9.1. Introduction
9.2. Biodegradable
9.2.1. Pcl
9.2.2. Pla
9.2.3. Plga
9.3. Non-Biodegradable
9.3.1. Ethylene-Vinyl Acetate
9.3.2. Polyacrylate
9.3.3. Silicon
10. Controlled Release Drug Delivery Market, by Type
10.1. Introduction
10.2. Chemically-Controlled
10.2.1. Iontophoresis
10.2.2. pH Sensitive
10.2.3. Protonation
10.3. Diffusion-Controlled
10.4. Dissolution-Controlled
10.5. Osmotic
10.6. Stimuli-Induced
10.6.1. Magnetic
10.6.2. Temperature
10.6.3. Ultrasound
11. Controlled Release Drug Delivery Market, by Application
11.1. Introduction
11.2. Cardiovascular
11.3. CNS Disorders
11.4. Infectious Diseases
11.5. Oncology
11.6. Pain Management
12. Controlled Release Drug Delivery Market, by Technology
12.1. Introduction
12.2. Liposomes
12.2.1. Conventional
12.2.2. Ligand-Targeted
12.2.3. PEGylated
12.3. Microencapsulation
12.3.1. Coacervation
12.3.2. Solvent Evaporation
12.3.3. Spray Drying
12.4. Microspheres
12.4.1. Chitosan
12.4.2. Gelatin
12.4.3. PLGA
12.5. Nanoparticles
12.5.1. Dendrimer
12.5.2. Inorganic
12.5.3. Lipid Based
12.5.4. Polymeric
13. Controlled Release Drug Delivery Market, by Drug Type
13.1. Introduction
13.2. Biologics
13.2.1. Monoclonal Antibodies
13.2.2. Peptides
13.2.3. Proteins
13.2.4. Vaccines
13.3. Small Molecule
14. Controlled Release Drug Delivery Market, by End User
14.1. Introduction
14.2. Clinics
14.3. Home Healthcare
14.4. Hospitals
14.5. Specialty Centers
15. Americas Controlled Release Drug Delivery Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Controlled Release Drug Delivery Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Controlled Release Drug Delivery Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Johnson & Johnson
18.3.2. Pfizer Inc.
18.3.3. F. Hoffmann-La Roche Ltd
18.3.4. AbbVie Inc.
18.3.5. Merck & Co., Inc.
18.3.6. Novartis AG
18.3.7. Sanofi S.A.
18.3.8. Bristol-Myers Squibb Company
18.3.9. GlaxoSmithKline plc
18.3.10. AstraZeneca plc
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET MULTI-CURRENCY
FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET MULTI-LANGUAGE
FIGURE 3. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PULMONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PCL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ETHYLENE-VINYL ACETATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SILICON, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH SENSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTONATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DIFFUSION-CONTROLLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DISSOLUTION-CONTROLLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TEMPERATURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIGAND-TARGETED, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEGYLATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SOLVENT EVAPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPRAY DRYING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DENDRIMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPID BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 114. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 115. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 116. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 117. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 118. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 120. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 121. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 124. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 125. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 126. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 127. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 129. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 213. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 217. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 218. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 221. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 222. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 224. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 226. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 228. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 229. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 233. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 234. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 237. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 238. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 239. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 241. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 260. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 261. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 262. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 263. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 265. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 266. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 269. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 270. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 271. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 272. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 274. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 276. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 277. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 278. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 279. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 281. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 282. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NON-BIODEGRADABLE, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Controlled Release Drug Delivery market report include:
  • Johnson & Johnson
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • AstraZeneca plc

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 51.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.7 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030 - Product Image

Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Controlled Release Drug Delivery Market Report 2025 - Product Image

Controlled Release Drug Delivery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From

About the Controlled Drug Delivery Market

The Controlled Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the development and delivery of drugs to patients. Controlled Drug Delivery is a type of drug delivery system that allows for the precise and controlled release of drugs over a predetermined period of time. This type of drug delivery system is beneficial for patients who require a steady and consistent dose of medication over a long period of time. It also helps to reduce the risk of side effects and drug interactions. The Controlled Drug Delivery market is composed of a variety of companies that specialize in the development and delivery of controlled drug delivery systems. These companies include Novartis, Pfizer, Merck, Sanofi, and Johnson & Johnson. Additionally, there are a number of smaller companies that specialize in the development of drug delivery systems, such as AptarGroup, 3M, and West Pharmaceutical Services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.